Elsamitrucin
Elsamitrucin
Elsamitrucin (pronunciation: el-sa-mi-tru-cin) is a chemotherapeutic agent used in the treatment of various types of cancer. It is a semi-synthetic derivative of the natural compound Elsamicin A, which is isolated from the bacterium Actinomycete.
Etymology
The term "Elsamitrucin" is derived from the name of its parent compound, Elsamicin A. The suffix "-trucin" is commonly used in the nomenclature of chemotherapeutic agents.
Usage
Elsamitrucin is primarily used in the treatment of leukemia, lymphoma, and certain solid tumors. It works by inhibiting the growth of cancer cells and eventually causing their death.
Mechanism of Action
Elsamitrucin exerts its anti-cancer effects by binding to the DNA of cancer cells and inhibiting the enzyme topoisomerase II, which is essential for DNA replication and cell division. This leads to DNA damage and cell death.
Side Effects
Common side effects of Elsamitrucin include nausea, vomiting, hair loss, and fatigue. More serious side effects can include bone marrow suppression, leading to a decrease in blood cell counts.
Related Terms
External links
- Medical encyclopedia article on Elsamitrucin
- Wikipedia's article - Elsamitrucin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski